In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice

Japanese Journal of Cancer Research

Volumn 90, Issue 10, 1999, Pages 1163-1170

  Arakawa, Hiroharu ^a   Morita, Masashi ^a   Kodera, Tsutomu ^a   Okura, Akira ^a   Ohkubo, Mitsuru ^a   Morishima, Hajime ^a   Nishimura, Susumu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anti tumor; Indolocarbazole; J 107088; Metastasis; Toxicity

Indexed keywords

CARBAZOLE DERIVATIVE; CISPLATIN; DNA TOPOISOMERASE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; DRUG RESPONSE; ENZYME INHIBITION; FEMALE; LIVER METASTASIS; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SOLID TUMOR;

EID: 0032702777     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00691.x     Document Type: Article

References (12)

1. Yoshinari, T., Matsumoto, M., Arakawa, H., Okada, H., Noguchi, K., Suda, H., Okura, A. and Nishimura, S. Novel antitumor indolocarbazole compound 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a] pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity. Cancer Res., 55, 1310-1315 (1995).
2. Arakawa, H., Iguchi, T., Morita, M., Yoshinari, T., Kojiri, K., Suda, H., Okura, A. and Nishimura, S. Novel indolocarbazole compound 6-N-formylamino-2,13-dihydro-1,11-dihydroxy-13-(β-D-glucopyranosyl)-5H- indolo[2,3-a]pyrrolo-[3,4-c]carbazole-5,7(6H)-dione (NB-506): its potent antitumor activity in mice. Cancer Res., 55, 1316-1320 (1995).
3. Yoshinari, T., Ohkubo, M., Fukasawa, K., Egashira, S., Hara, Y., Matsumoto, M., Nakai, K., Arakawa, H., Morishima, H. and Nishimura, S. Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I. Cancer Res., 59, 4271-4275 (1999).
4. Arakawa, H., Matsumoto, H., Morita, M., Sasaki, M., Taguchi, K., Okura, A. and Nishimura, S. Antimetastatic effect of a novel indolocarbazole (NB-506) on IMC-HM murine tumor cells metastasized to the liver. Jpn. J. Cancer Res., 87, 518-523 (1996).
5. Ohkubo, M., Nishimura, T., Jona, H., Honma, T. and Morishima, H. Practical synthesis of indolopyrrolocarbazoles. Tetrahedron, 52, 8099-8112 (1996).
6. Dexter, D. L., Hesson, D. P., Ardecky, R. J., Rao, G. V., Tippett, D. L., Dusak, B. A., Paull, K. D., Plowman, J., DeLarco, B. M., Narayanan, V. L. and Forbes, M. Activity of a novel 4-quinolinecarboxylic acid, NSC 3688390 [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4- quinolinecarboxylic acid sodium salt], against experimental tumors. Cancer Res., 45, 5563-5568 (1985).
7. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. and Skipper, H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep., 50, 219-244 (1966).
8. Kojiri, K., Kondo, H., Yoshinari, T., Arakawa, H., Nakajima, S., Satoh, F., Kawamura, K., Okura, A., Suda, H. and Okanishi, M. A new antitumor substance, BE-13793C, produced by a streptomycete. Taxonomy, fermentation, isolation, structure determination and biological activity. J. Antibiot. (Tokyo), 44, 723-728 (1991).
9. Arakawa, H., Iguchi, T., Yoshinari, T., Kojiri, K., Suda, H. and Okura, A. ED-110, a novel indolocarbazole, prevents the growth of experimental tumors in mice. Jpn. J. Cancer Res., 84, 574-581 (1993).
10. Yoshinari, T., Yamada, A., Uemura, D., Nomura, K., Arakawa, H., Kojiri, K., Yoshida, E., Suda, H. and Okura, A. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110. Cancer Res., 53, 490-494 (1993).
11. Ohkubo, M., Kojiri, K., Kondo, H., Tanaka, S., Kawamoto, H., Nishimura, T., Nishimura, I., Yoshinari, T., Arakawa, H., Suda, H., Morishima, H. and Nishimura, S. Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506. Bioorg. Med. Chem. Lett., 9, 1219-1224 (1999).
12. Bailly, C., Qu, X., Chaires, J. B., Colson, P., Houssier, C., Ohkubo, M., Nishimura, S. and Yoshinari, T. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities. J. Med. Chem., 42, 2927-2935 (1999).